乐普医疗
(300003)
| 流通市值：189.00亿 | | | 总市值：220.66亿 |
| 流通股本：15.79亿 | | | 总股本：18.43亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,626,725,903.3 | 3,214,194,092.31 | 1,672,061,164 | 6,482,731,703.55 |
| 营业收入 | 4,626,725,903.3 | 3,214,194,092.31 | 1,672,061,164 | 6,482,731,703.55 |
| 二、营业总成本 | 3,998,311,192.6 | 2,744,393,418.86 | 1,409,787,783.97 | 5,250,530,600.6 |
| 营业成本 | 1,852,216,186.81 | 1,258,141,389.55 | 634,808,816.67 | 2,333,260,819.22 |
| 税金及附加 | 58,580,978.35 | 40,920,942.73 | 20,552,615.32 | 86,070,176.78 |
| 销售费用 | 712,520,740.05 | 492,833,491.56 | 246,567,331.93 | 1,169,073,499.05 |
| 管理费用 | 459,256,497.98 | 303,761,967.76 | 129,204,899.17 | 708,801,631.32 |
| 研发费用 | 717,770,567.22 | 476,848,231.31 | 240,543,630.48 | 792,378,182.97 |
| 财务费用 | 197,966,222.19 | 171,887,395.95 | 138,110,490.4 | 160,946,291.26 |
| 其中:利息费用 | 221,534,782.03 | 182,886,263.41 | 147,372,601.3 | 176,640,432.24 |
| 其中:利息收入 | 50,850,309.23 | 36,372,592.3 | 23,131,859.32 | 71,511,762.48 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -700,185.62 | -644,866.85 | -133,143.42 | 1,553,088.27 |
| 加:投资收益 | -661,294.49 | 13,340,381.23 | 738,994.03 | 49,445,188.28 |
| 资产处置收益 | 2,428,481.97 | 336,498.9 | -82,367.26 | 4,867,354.39 |
| 资产减值损失(新) | -2,923,409.29 | -1,143,957.04 | -792,259.96 | -149,398,467.01 |
| 信用减值损失(新) | -33,849,375.5 | -29,944,756.49 | -18,860,779.23 | -64,052,178.08 |
| 其他收益 | 61,276,214.42 | 45,354,677.61 | 21,381,843.22 | 145,454,340.54 |
| 四、营业利润 | 653,985,142.19 | 497,098,650.81 | 264,525,667.41 | 1,220,070,429.34 |
| 加:营业外收入 | 6,434,063.93 | 4,264,472.11 | 712,541.71 | 14,437,343.11 |
| 减:营业外支出 | 20,049,821.97 | 16,380,316.17 | 6,449,667.29 | 18,429,646.55 |
| 五、利润总额 | 640,369,384.15 | 484,982,806.75 | 258,788,541.83 | 1,216,078,125.9 |
| 减:所得税费用 | 38,737,705.77 | 28,387,905.19 | 35,595,155.2 | 197,074,523.65 |
| 六、净利润 | 601,631,678.38 | 456,594,901.56 | 223,193,386.63 | 1,019,003,602.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 601,631,678.38 | 456,594,901.56 | 223,193,386.63 | 1,019,003,602.25 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 678,288,593.36 | 499,475,609.79 | 246,814,412.34 | 962,006,332.53 |
| 少数股东损益 | -76,656,914.98 | -42,880,708.23 | -23,621,025.71 | 56,997,269.72 |
| 扣除非经常损益后的净利润 | 650,328,915.59 | 480,755,800.14 | 241,404,755.77 | 842,496,754.92 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.37 | 0.27 | 0.13 | 0.52 |
| (二)稀释每股收益 | 0.37 | 0.27 | 0.13 | 0.52 |
| 八、其他综合收益 | 227,861,621.44 | 95,706,565.98 | 73,949,750.34 | 351,080,547.85 |
| 归属于母公司股东的其他综合收益 | 231,061,983.44 | 97,653,708.84 | 75,105,312.39 | 355,164,586.09 |
| 九、综合收益总额 | 829,493,299.82 | 552,301,467.54 | 297,143,136.97 | 1,370,084,150.1 |
| 归属于母公司股东的综合收益总额 | 909,350,576.8 | 597,129,318.63 | 321,919,724.73 | 1,317,170,918.62 |
| 归属于少数股东的综合收益总额 | -79,857,276.98 | -44,827,851.09 | -24,776,587.76 | 52,913,231.48 |
| 公告日期 | 2026-10-24 | 2026-08-22 | 2026-04-23 | 2026-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |